Online Dating During COVID-19 and Cancer: What to Know
In this post, Dr. Anne Katz and Ian Scott discuss what to know about online dating during the COVID-19 pandemic when you have cancer.
In this post, Dr. Anne Katz and Ian Scott discuss what to know about online dating during the COVID-19 pandemic when you have cancer.
In this post, Dr. Ann Meredith Garcia Trinidad describes how people with cancer and caregivers can best use social media for support both during and after cancer.
In this podcast, Dr. Norah Lynn Henry describes new research and updates presented at the 2020 San Antonio Breast Cancer Symposium (SABCS) for people with hormone receptor-positive breast cancer, including for cancer that is also HER2-negative and has spread to the lymph nodes.
In this post, Dr. Matthew Schabath discusses the unique challenges LGBTQ people with cancer face throughout their experience, what resources are available to help, and how the health care community is working to eliminate disparities in care.
Dr. Elyce Cardonick discusses the unique challenges of facing cancer while pregnant and how patients can navigate pregnancy while receiving cancer treatment.
In this podcast, Dr. Michael Williams discusses studies and a report on the treatment of leukemia and lymphoma presented at last month’s ASH Annual Meeting.
In this “Your Stories” podcast from Conquer Cancer, the ASCO Foundation, Dr. Mark Applebaum discusses what it’s like to provide care for children with cancer and how research can help kids live more comfortably through the cancer experience.
In this month’s "From the Editor’s Desk," Dr. Lidia Schapira reflects on the difficulties of 2020 during the COVID-19 pandemic and how people with cancer can find hope as 2021 begins.
In this Q&A, Dr. Anne Katz and Dr. Brad Zebrack discuss some of the challenges that teenagers and young adults with cancer face, including issues around sexual identity, faith, isolation, and relationships.
In the latest podcast in the “Clinical Trials in Genitourinary Cancers” series, experts discuss 3 clinical trials testing new treatments for prostate, bladder, and kidney cancers.